STEFAN GILTHORPE: Open Payments
NPI 1245677145 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$837 in 35 payments from 15 companies in 2025. Trend: 2023 $2,149 · 2024 $323 · 2025 $837
Food & beverage: $837
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation | 1 | $157 |
| Averitas Pharma Inc. | 8 | $106 |
| Valinor Pharma, LLC | 7 | $89 |
| Medtronic, Inc. | 3 | $74 |
| SPR Therapeutics, Inc | 2 | $62 |
| SI-BONE, INC. | 1 | $59 |
| Nalu Medical, Inc. | 2 | $58 |
| Globus Medical, Inc. | 2 | $57 |
| Boston Scientific Corporation | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
Products named: OPTABLATE, QUTENZA, MOVANTIK, SPRINT PNS System, Nalu Neurostimulation System, INCEPTIV, General - Pain Management, Belbuca.
Industry payments across TX — which companies pay providers there.
